dactinomycin and defibrotide

dactinomycin has been researched along with defibrotide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ochmański, W1
Carboné, A; Garcia-Iñiguez, JP; Madurga, P; Martín-Lázaro, JF; Palanca, D1
Choi, A; Kang, YK; Kim, DH; Lee, JA; Lim, JS; Lim, S1

Trials

1 trial(s) available for dactinomycin and defibrotide

ArticleYear
[Influence of antiplatelet drugs (AD) on the efectiveness of combined therapy in patients with small cell lung cancer. Part I. Influence of AD on the haemostatic system].
    Przeglad lekarski, 2008, Volume: 65, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Blood Coagulation; Carcinoma, Small Cell; Cyclophosphamide; Dactinomycin; Humans; Lung Neoplasms; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Polydeoxyribonucleotides; Radiotherapy, Adjuvant; Survival Rate; Ticlopidine; Vincristine

2008

Other Studies

2 other study(ies) available for dactinomycin and defibrotide

ArticleYear
Hepatopathy-thrombocytopenia syndrome after actinomycin-D therapy: treatment with defibrotide.
    Pediatric hematology and oncology, 2013, Volume: 30, Issue:1

    Topics: Adolescent; Chemical and Drug Induced Liver Injury; Compassionate Use Trials; Dactinomycin; Female; Humans; Polydeoxyribonucleotides; Syndrome; Thrombocytopenia; Wilms Tumor

2013
Severe Hepatic Sinusoidal Obstruction Syndrome in a Child Receiving Vincristine, Actinomycin-D, and Cyclophosphamide for Rhabdomyosarcoma: Successful Treatment with Defibrotide.
    Cancer research and treatment, 2016, Volume: 48, Issue:4

    Topics: Child; Cyclophosphamide; Dactinomycin; Female; Hepatic Veno-Occlusive Disease; Humans; Liver; Polydeoxyribonucleotides; Rhabdomyosarcoma; Vincristine

2016